Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.
Filion KB, Lix LM, Yu OH, Dell'Aniello S, Douros A, Shah BR, St-Jean A, Fisher A, Tremblay E, Bugden SC, Alessi-Severini S, Ronksley PE, Hu N, Dormuth CR, Ernst P, Suissa S; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.
Filion KB, et al. Among authors: ernst p.
BMJ. 2020 Sep 23;370:m3342. doi: 10.1136/bmj.m3342.
BMJ. 2020.
PMID: 32967856
Free PMC article.